150 related articles for article (PubMed ID: 38281354)
1. The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction - A systematic review.
Chong JH; Chang WT; Chan JJ; Tan TJY; Chan JWK; Wong M; Wong FY; Chuah CTH
Curr Probl Cardiol; 2024 Mar; 49(3):102372. PubMed ID: 38281354
[TBL] [Abstract][Full Text] [Related]
2. A review regarding the article 'The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction-A systematic review'.
Zhao G; Wang L; Fang H; Wang L
Curr Probl Cardiol; 2024 May; 49(5):102526. PubMed ID: 38492616
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
Täger T; Atar D; Agewall S; Katus HA; Grundtvig M; Cleland JGF; Clark AL; Fröhlich H; Frankenstein L
Heart Fail Rev; 2021 Nov; 26(6):1421-1435. PubMed ID: 32314085
[TBL] [Abstract][Full Text] [Related]
5. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis.
Li HL; Lip GYH; Feng Q; Fei Y; Tse YK; Wu MZ; Ren QW; Tse HF; Cheung BY; Yiu KH
Cardiovasc Diabetol; 2021 May; 20(1):100. PubMed ID: 33962654
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis.
Zhang N; Wang Y; Tse G; Korantzopoulos P; Letsas KP; Zhang Q; Li G; Lip GYH; Liu T
Eur J Prev Cardiol; 2022 Feb; 28(17):1961-1973. PubMed ID: 34792124
[TBL] [Abstract][Full Text] [Related]
7. The Use of Sodium-Glucose Cotransporter-2 Inhibitors in Coronary Revascularization: Where Are We Now? A Systematic Review.
El-Andari R; Fialka NM; Kang J; Bozso SJ; Nagendran J; Nagendran J
Am J Cardiovasc Drugs; 2024 Jan; 24(1):55-69. PubMed ID: 37975979
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab-containing regimens for metastatic breast cancer.
Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of sodium-glucose cotransporter 2 inhibitors: a hopeful prospect in tackling heart failure-related events.
Aziri B; Begic E; Jankovic S; Mladenovic Z; Stanetic B; Kovacevic-Preradovic T; Iglica A; Mujakovic A
ESC Heart Fail; 2023 Jun; 10(3):1499-1530. PubMed ID: 36967133
[TBL] [Abstract][Full Text] [Related]
10. Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis.
Li M; Yi T; Fan F; Qiu L; Wang Z; Weng H; Ma W; Zhang Y; Huo Y
Cardiovasc Diabetol; 2022 Jul; 21(1):139. PubMed ID: 35879763
[TBL] [Abstract][Full Text] [Related]
11. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose-response meta-analysis involving 10 randomized clinical trials and 71 553 individuals.
Lin DS; Yu AL; Lo HY; Lien CW; Lee JK; Chiang FT; Tu YK
Eur J Endocrinol; 2023 Jul; 189(1):S17-S25. PubMed ID: 37474112
[TBL] [Abstract][Full Text] [Related]
13. Sodium-glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review.
Rasalam R; Atherton JJ; Deed G; Molloy-Bland M; Cohen N; Sindone A
ESC Heart Fail; 2021 Oct; 8(5):4093-4118. PubMed ID: 34219407
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.
Yu AF; Singh JC; Wang R; Liu JE; Eaton A; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Oncologist; 2017 Jun; 22(6):642-647. PubMed ID: 28341761
[TBL] [Abstract][Full Text] [Related]
15. The Role of SGLT2 Inhibitors on Heart Failure Outcomes in Nondiabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Kommu S
J Cardiovasc Pharmacol; 2024 Feb; 83(2):158-166. PubMed ID: 37989136
[TBL] [Abstract][Full Text] [Related]
16. Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study.
Abdel-Qadir H; Bobrowski D; Zhou L; Austin PC; Calvillo-Argüelles O; Amir E; Lee DS; Thavendiranathan P
J Am Heart Assoc; 2021 Jan; 10(2):e018393. PubMed ID: 33401953
[TBL] [Abstract][Full Text] [Related]
17. Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer.
Chiang CH; Chiang CH; Chiang CH; Ma KS; Peng CY; Hsia YP; Horng CS; Chen CY; Chang YC; See XY; Chen YJ; Wang SS; Suero-Abreu GA; Peterson LR; Thavendiranathan P; Armand P; Peng CM; Shiah HS; Neilan TG
Heart; 2023 Feb; 109(6):470-477. PubMed ID: 36351793
[TBL] [Abstract][Full Text] [Related]
18. Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative review.
Jafari L; Akhter N
Breast Cancer Res Treat; 2021 Apr; 186(2):295-303. PubMed ID: 33481134
[TBL] [Abstract][Full Text] [Related]
19. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
[TBL] [Abstract][Full Text] [Related]
20. Safety of sodium-glucose cotransporter 2 inhibitors drugs among heart failure patients: a systematic review and meta-analysis.
Soleimani H; Saeedian B; Pasebani Y; Babajani N; Pashapour Yeganeh A; Bahirai P; Navid H; Amin A; Samsky MD; Nanna MG; Hosseini K
ESC Heart Fail; 2024 Apr; 11(2):637-648. PubMed ID: 38124239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
